本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BioNTech SE

110.02
-1.0200-0.92%
盤後110.00-0.0200-0.02%19:39 EDT
成交量:61.66萬
成交額:6,781.16萬
市值:264.05億
市盈率:-31.91
高:111.78
開:111.78
低:109.48
收:111.04
資料載入中...
2024/09/16

關聯方擬減持公告

Form 144 | BioNTech SE 10%股東 ATHOS KG 擬減持50萬股,總價約6170萬美元
2024/09/16

關聯方擬減持公告

Form 144 | BioNTech SE 股東 ATHOS KG 擬減持90000股,總價約1134萬美元
2024/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/20

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/03/27

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/22

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/13

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/26

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]